** Shares of vaccine makers Moderna MRNA.O, Novavax NVAX.O and Pfizer PFE.N gain as White House withdraws nomination of vaccine critic Dave Weldon to serve as director of the U.S. Centers for Disease Control and Prevention
** Moderna MRNA.O climbs 4.17% to $36.47, Novavax NVAX.O rises 1.85% to $8.25 and Pfizer PFE.N up marginally
** The former Republican congressman had been scheduled to appear before the Senate Health, Education, Labor and Pensions Committee on Thursday for a confirmation hearing
** The committee confirmed the withdrawal of the nomination and said the hearing had been canceled
** The stocks have been under pressure since Trump was elected for a second term, and selected well-known vaccine skeptic Robert F. Kennedy Jr to lead the Department of Health and Human Services, U.S.'s top health agency
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.